Related Experiment Videos
[Retinitis in an infant infected with HIV].
T Jonckheer1, A de Selys, C Pierre
1Institut de Médecine Tropicale, Antwerpen.
Summary
A cytomegalovirus (CMV) retinitis case in an HIV-infected infant was successfully treated with AZT and intravenous immunoglobulin. The infant showed full recovery and no recurrence after four months of follow-up.
Area of Science:
- Ophthalmology
- Pediatrics
- Infectious Diseases
Background:
- Cytomegalovirus (CMV) retinitis is a serious opportunistic infection in infants with Human Immunodeficiency Virus (HIV).
- Early diagnosis and prompt treatment are crucial for preventing vision loss in affected infants.
Observation:
- A 7-month-old infant with HIV presented with unilateral left retinitis.
- Urine culture confirmed the presence of cytomegalovirus (CMV).
Findings:
- Treatment with AZT (azidothymidine) and monthly intravenous immunoglobulin resulted in complete resolution of retinitis within 3 weeks.
- No recurrence of retinitis was observed during a 4-month follow-up period.
Implications:
- This case highlights the effectiveness of combined antiviral and immunomodulatory therapy for CMV retinitis in HIV-infected infants.
- Challenges in diagnosing and assessing treatment response for CMV retinitis in pediatric HIV cases are noted.